144 related articles for article (PubMed ID: 16782344)
21. A cascade of acid-promoted C-O bond cleavage and redox reactions: from oxa-bridged benzazepines to benzazepinones.
Zhang Y; Yang F; Zheng L; Dang Q; Bai X
Org Lett; 2014 Dec; 16(23):6041-3. PubMed ID: 25397583
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists.
Xiang MA; Chen RH; Demarest KT; Gunnet J; Look R; Hageman W; Murray WV; Combs DW; Rybczynski PJ; Patel M
Bioorg Med Chem Lett; 2004 Jun; 14(12):3143-6. PubMed ID: 15149662
[TBL] [Abstract][Full Text] [Related]
23. Solid-supported solution-phase synthesis of 4-amino-1,2,4,5-tetrahydro-2-benzazepine-3-ones.
Van den Eynde I; Van Rompaey K; Lazzaro F; Tourwé D
J Comb Chem; 2004; 6(4):468-73. PubMed ID: 15244406
[TBL] [Abstract][Full Text] [Related]
24. Tolvaptan, an oral vasopressin V2 receptor antagonist for heart failure?
Greenberg A
Am J Kidney Dis; 2007 Dec; 50(6):904-7. PubMed ID: 18037090
[No Abstract] [Full Text] [Related]
25. Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia.
Madias NE
Am J Kidney Dis; 2007 Aug; 50(2):184-7. PubMed ID: 17660019
[No Abstract] [Full Text] [Related]
26. Synthesis and Characterization of New V
Szeleczky Z; Szakács Z; Bozó É; Baska F; Vukics K; Lévai S; Temesvári K; Vass E; Béni Z; Krámos B; Magdó I; Szántay C; Kóti J; Domány-Kovács K; Greiner I; Bata I
J Med Chem; 2021 Jul; 64(14):10445-10468. PubMed ID: 34255509
[TBL] [Abstract][Full Text] [Related]
27. Asymmetric synthesis of enantiomerically pure 2-substituted tetrahydro-3-benzazepines and their affinity to sigma1 receptors.
Husain SM; Fröhlich R; Schepmann D; Wünsch B
J Org Chem; 2009 Apr; 74(7):2788-93. PubMed ID: 19267485
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 7-alkylidene-7,12-dihydroindolo[3,2-d]benzazepine-6-(5H)-ones (7-alkylidene-paullones) by N-cyclization-oxidative Heck cascade and characterization as sirtuin modulators.
Denis JG; Franci G; Altucci L; Aurrecoechea JM; de Lera ÁR; Álvarez R
Org Biomol Chem; 2015 Mar; 13(9):2800-10. PubMed ID: 25604354
[TBL] [Abstract][Full Text] [Related]
29. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
[TBL] [Abstract][Full Text] [Related]
30. Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies.
Xiang MA; Rybczynski PJ; Patel M; Chen RH; McComsey DF; Zhang HC; Gunnet JW; Look R; Wang Y; Minor LK; Zhong HM; Villani FJ; Demarest KT; Damiano BP; Maryanoff BE
Bioorg Med Chem Lett; 2007 Dec; 17(23):6623-8. PubMed ID: 17942308
[TBL] [Abstract][Full Text] [Related]
31. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
Udelson JE; Orlandi C; Ouyang J; Krasa H; Zimmer CA; Frivold G; Haught WH; Meymandi S; Macarie C; Raef D; Wedge P; Konstam MA; Gheorghiade M
J Am Coll Cardiol; 2008 Nov; 52(19):1540-5. PubMed ID: 19007589
[TBL] [Abstract][Full Text] [Related]
32. Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.
Smith BM; Smith JM; Tsai JH; Schultz JA; Gilson CA; Estrada SA; Chen RR; Park DM; Prieto EB; Gallardo CS; Sengupta D; Dosa PI; Covel JA; Ren A; Webb RR; Beeley NR; Martin M; Morgan M; Espitia S; Saldana HR; Bjenning C; Whelan KT; Grottick AJ; Menzaghi F; Thomsen WJ
J Med Chem; 2008 Jan; 51(2):305-13. PubMed ID: 18095642
[TBL] [Abstract][Full Text] [Related]
33. Heck-Suzuki Tandem Reaction for the Synthesis of 3-Benzazepines.
Peshkov AA; Peshkov VA; Pereshivko OP; Van Hecke K; Kumar R; Van der Eycken EV
J Org Chem; 2015 Jul; 80(13):6598-608. PubMed ID: 25996648
[TBL] [Abstract][Full Text] [Related]
34. A general route to the synthesis of 1,5-methano- and 1,5-ethano- 2,3,4,5-tetrahydro-1H-3-benzazepines.
O'Donnell CJ; Singer RA; Brubaker JD; McKinley JD
J Org Chem; 2004 Aug; 69(17):5756-9. PubMed ID: 15307752
[TBL] [Abstract][Full Text] [Related]
35. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activities of novel furo[2,3,4-jk][2]benzazepin-4(3H)-one derivatives.
Ando K; Akai Y; Kunitomo J; Yokomizo T; Nakajima H; Takeuchi T; Yamashita M; Ohta S; Ohishi T; Ohishi Y
Org Biomol Chem; 2007 Feb; 5(4):655-63. PubMed ID: 17285174
[TBL] [Abstract][Full Text] [Related]
37. Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
Ali F; Raufi MA; Washington B; Ghali JK
Cardiovasc Drug Rev; 2007; 25(3):261-79. PubMed ID: 17919259
[TBL] [Abstract][Full Text] [Related]
38. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of a 6-aryloxymethyl-5-hydroxy-2,3,4,5-tetrahydro-[1H]-2-benzazepin-4-one: a muscarinic (M3) antagonist.
Evans P; Lee AT; Thomas EJ
Org Biomol Chem; 2008 Jun; 6(12):2158-67. PubMed ID: 18528577
[TBL] [Abstract][Full Text] [Related]
40. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
